Sen. Charles Grassley file photo
WAX20010201 - 02 JANUARY 2001 - WASHINGTON, DC, USA: Sen. Charles Grassley (R-IA)speaks in Washington, DC in this August 20, 1997 file photo. Goes with story on Sen. Grassley. bc/Ricardo Watson UPI
UPI Related News
WASHINGTON, Sept. 16 (UPI) -- Sen. Charles Grassley, R-Iowa, sparred with FBI chief Robert Mueller about a proposal Grassley said would have stripped protections for FBI whistle-blowers.
WASHINGTON, Aug. 23 (UPI) -- Sens. Charles Grassley, R-Iowa, and Kent Conrad, D-N.D., agreed Sunday that a "public option" component won't be part of a healthcare reform package.
WASHINGTON, Aug. 19 (UPI) -- The White House and top U.S. Senate Democrats are considering a strategy of breaking healthcare legislation into two major parts, The Wall Street Journal said.
WASHINGTON, Aug. 2 (UPI) -- U.S. Sen. John McCain, R-Ariz., said Sunday he won't automatically support healthcare reform compromises being hammered out in Congress.
WASHINGTON, July 30 (UPI) -- Two U.S. Republican senators working with Democrats to craft a bipartisan healthcare bill said they thought a deal won't be struck before the August recess.
WASHINGTON, June 14 (UPI) -- Senate Banking Committee Chairman Chris Dodd said Sunday he is opposed to taxing benefits paid to U.S. workers under a healthcare reform bill in Congress.
NEW YORK, May 19 (UPI) -- Sen. Charles Grassley, R-Iowa, has raised concerns about BlackRock, a little known New York firm playing many roles in the economic recovery process.
WASHINGTON, Feb. 11 (UPI) -- William Lynn's nomination by President Obama to be No. 2 at the Pentagon was confirmed by the full Senate Wednesday after a debate that revealed dramatically different perceptions about his record.
MADISON, Wis., Jan. 18 (UPI) -- A surgeon at the University of Wisconsin-Madison received millions of dollars from a medical device company, Sen. Charles Grassley, R-Iowa, says.
ATLANTA, Dec. 23 (UPI) -- A prominent psychiatrist has been punished by Emory University in Atlanta for failing to report thousands of dollars in fees from a pharmaceutical company.
